Westpac Banking Corp’s NovoCure NVCR Stock Holding History

Westpac Banking Corp’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-6,997	Closed	-$421K	–	689
2023 Q1	$421K	Hold	6,997	–	–	0.01%	755
2022 Q4	$513K	Hold	6,997	–	–	0.01%	695
2022 Q3	$532K	Hold	6,997	–	–	0.01%	702
2022 Q2	$486K	Hold	6,997	–	–	0.01%	757
2022 Q1	$580K	Hold	6,997	–	–	0.01%	766
2021 Q4	$525K	Hold	6,997	–	–	0.01%	782
2021 Q3	$813K	Hold	6,997	–	–	0.01%	750
2021 Q2	$1.55M	Buy	+6,997	New	+$1.36M	0.02%	665
2021 Q1	–	Sell	-6,997	Closed	-$1.21M	–	825
2020 Q4	$1.21M	Buy	+6,997	New	+$957K	0.01%	676

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Nordwand Advisors Radnor, Pennsylvania $572M AUM 23.09% 1-Year Est. Return

Westpac Banking Corp's NVCR Position: Q2 2023 in Review

Westpac Banking Corp sold out of NovoCure (NVCR) in Q2 2023, closing a stake of 6,997 shares — an estimated $421K sold.

Westpac Banking Corp first reported a position in NVCR in Q4 2020 and held it in 9 quarters. The position peaked at $1.55M in Q2 2021. 267 funds tracked by Wall St. Rank hold NVCR as of Q2 2023.

Westpac Banking Corp reported no remaining NovoCure position as of Q2 2023 after selling out during the quarter.
Westpac Banking Corp sold 6,997 NovoCure shares in Q2 2023, an estimated $421K.
Westpac Banking Corp first reported a position in NovoCure in Q4 2020 and held it in 9 quarters.
Westpac Banking Corp's NovoCure position peaked at $1.55M in Q2 2021.
267 funds tracked by Wall St. Rank held NovoCure as of Q2 2023.

Based on Westpac Banking Corp's 13F filing for Q2 2023, filed 10 Aug 2023.